206 related articles for article (PubMed ID: 1675867)
21. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Pouleur H; Hanet C; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
[TBL] [Abstract][Full Text] [Related]
22. Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trial.
de Feyter PJ; Serruys PW
Eur Heart J; 1990 Apr; 11 Suppl A():48-9. PubMed ID: 1971590
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
[TBL] [Abstract][Full Text] [Related]
24. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
25. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
26. [Effects of xamoterol in moderate cardiac insufficiency].
Kayanakis JG; Larouchi L; Doat P; Grenet B; Fauvel JM; Bounhoure JP
Presse Med; 1989 Apr; 18(13):667-70. PubMed ID: 2566161
[TBL] [Abstract][Full Text] [Related]
27. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.
Galiè N; Metalli M; Zannoli R; Binetti G; Branzi A; Magnani B
Cardiovasc Drugs Ther; 1989 Mar; 3(1):91-7. PubMed ID: 2577281
[TBL] [Abstract][Full Text] [Related]
28. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
29. [Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
Erlemeier HH; Kupper W; Bleifeld W
Z Kardiol; 1990 Feb; 79(2):126-33. PubMed ID: 1969685
[TBL] [Abstract][Full Text] [Related]
30. Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol.
Vigholt-Sørensen E; Faergeman O
Br Heart J; 1990 Sep; 64(3):186-9. PubMed ID: 1976339
[TBL] [Abstract][Full Text] [Related]
31. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Osterziel KJ; Nagel F; Dietz R
Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
[TBL] [Abstract][Full Text] [Related]
32. Sympathetic modulation in practice: the German clinical experience.
Kupper W; Erlemeier HH; Bleifeld W
Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
[TBL] [Abstract][Full Text] [Related]
33. [Enalapril versus captopril in heart failure--effect on blood pressure and kidney function].
Osterziel KJ; Dietz R
Z Kardiol; 1991; 80 Suppl 2():28-34. PubMed ID: 2024541
[TBL] [Abstract][Full Text] [Related]
34. Effects of xamoterol (ICI 118,587) in asthmatic patients.
Löfdahl CG; Svedmyr N
Br J Clin Pharmacol; 1984 Oct; 18(4):597-601. PubMed ID: 6148960
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.
Kaasjager KA; Koomans HA; Rabelink TJ
Hypertension; 1995 Apr; 25(4 Pt 1):620-5. PubMed ID: 7721406
[TBL] [Abstract][Full Text] [Related]
36. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
Packer M; Lee WH; Kessler PD
Circulation; 1986 Oct; 74(4):766-74. PubMed ID: 3019586
[TBL] [Abstract][Full Text] [Related]
37. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
Marlow HF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
[TBL] [Abstract][Full Text] [Related]
38. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
Reams GP; Bauer JH
Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
[No Abstract] [Full Text] [Related]
40. Circadian rhythm of blood pressure in congestive heart failure and effects of ACE inhibitors.
Osterziel KJ; Dietz R; Lemmer B
Chronobiol Int; 1991; 8(5):420-31. PubMed ID: 1818790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
